Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAmphastar Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 2 | $0.71 | $0.72 | $0.72 |
| Q2 2025 | 1 | $0.75 | $0.77 | $0.76 |
| Q3 2025 | 1 | $0.82 | $0.84 | $0.84 |
| Q4 2025 | 1 | $0.95 | $0.97 | $0.96 |
| Q1 2026 | 1 | $0.82 | $0.84 | $0.83 |
| Q2 2026 | 1 | $0.85 | $0.87 | $0.86 |
| Q3 2026 | 1 | $0.95 | $0.97 | $0.96 |
| Q4 2026 | 1 | $0.93 | $0.95 | $0.94 |
Amphastar Pharmaceuticals, Inc. Earnings Date And Information
Amphastar Pharmaceuticals, Inc. last posted its earnings results on Thursday, February 27th, 2025. The company reported $0.92 earnings per share for the quarter, missing analysts' consensus estimates of $1.01 by $0.09. The company had revenue of 186.98 M for the quarter and had revenue of 712.81 M for the year. Amphastar Pharmaceuticals, Inc. has generated $3 earnings per share over the last year ($3.06 diluted earnings per share) and currently has a price-to-earnings ratio of 7.9. Amphastar Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
Amphastar Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/03/2025 | Q4 2024 | N/A | $0.79 | N/A | $188.76 M | $186.98 M |
| 11/07/2024 | Q3 2024 | N/A | $0.83 | N/A | $194.67 M | $188.82 M |
| 08/09/2024 | Q2 2024 | N/A | $0.78 | N/A | $170.96 M | $182.39 M |
| 05/09/2024 | Q1 2024 | N/A | $0.90 | N/A | N/A | $171.84 M |
| 02/29/2024 | Q4 2023 | N/A | $0.75 | N/A | $173.43 M | $178.11 M |
| 11/08/2023 | Q3 2023 | $0.69 | $1.01 | 0.32 | $174.63 M | $180.56 M |
| 08/08/2023 | Q2 2023 | N/A | $0.54 | N/A | $137.27 M | $145.71 M |
| 05/09/2023 | Q1 2023 | $0.48 | $0.54 | 0.06 | N/A | $140.02 M |
| 03/01/2023 | Q4 2022 | N/A | $0.70 | N/A | N/A | $135.02 M |
| 11/07/2022 | Q3 2022 | N/A | $0.30 | N/A | $125.98 M | $120.13 M |
| 08/08/2022 | Q2 2022 | N/A | $0.35 | N/A | $118.08 M | $123.47 M |
| 05/09/2022 | Q1 2022 | N/A | $0.47 | N/A | N/A | $120.37 M |
| 03/11/2022 | Q4 2021 | N/A | $0.41 | N/A | N/A | $120.89 M |
| 11/08/2021 | Q3 2021 | N/A | $0.62 | N/A | $103.25 M | $112.20 M |
| 08/09/2021 | Q2 2021 | $0.21 | $0.16 | -0.05 | $101.30 M | $101.66 M |
| 05/07/2021 | Q1 2021 | N/A | $0.11 | N/A | N/A | $103.02 M |
| 03/15/2021 | Q4 2020 | $0.14 | -$0.13 | -0.27 | N/A | $95.92 M |
| 11/06/2020 | Q3 2020 | $0.13 | $0.08 | -0.05 | $91.23 M | $83.43 M |
| 08/07/2020 | Q2 2020 | N/A | -$0.00 | N/A | $86.73 M | $85.81 M |
| 05/11/2020 | Q1 2020 | N/A | $0.09 | N/A | N/A | $84.69 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Amphastar Pharmaceuticals, Inc. Earnings: FAQ's
Amphastar Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based offlast year's report dates.
The conference call for Amphastar Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Amphastar Pharmaceuticals, Inc.'s latest earnings report can be read online.
Amphastar Pharmaceuticals, Inc. (:AMPH) has a recorded annual revenue of $712.81 M.
Amphastar Pharmaceuticals, Inc. (:AMPH) has a recorded net income of $159.52 M.Amphastar Pharmaceuticals, Inc. has generated $3.29 earnings per share over the last four quarters.
Amphastar Pharmaceuticals, Inc. (:AMPH) has a price-to-earnings ratio of 7.9 and price/earnings-to-growth ratio is 6.44.